Article

(2022) Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study. Journal of Diabetes and Metabolic Disorders. pp. 133-139.

(2022) Influence of cytotoxic T lymphocyte antigen 4 genetic variants on acute rejection in kidney transplant patients: precision medicine perspective. Journal of Diabetes and Metabolic Disorders. pp. 69-75.

(2021) Association analysis of HHEX gene variant with type 2 diabetes risk. International Journal of Diabetes in Developing Countries. pp. 43-47. ISSN 0973-3930

(2020) Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer. Urology Journal. pp. 271-275. ISSN 1735-1308

(2020) KCNQ1 common genetic variant and type 2 diabetes mellitus risk. Journal of Diabetes and Metabolic Disorders. pp. 47-51.

(2020) MTNR1B common genetic variant is associated with type 2 diabetes mellitus risk. Gene Reports. p. 4.

(2019) Association Analysis of the HNF4A Common Genetic Variants with Type 2 Diabetes Mellitus Risk. International Journal of Molecular and Cellular Medicine. pp. 56-62. ISSN 2251-9637

(2019) Kallikarein-related peptidase 3 common genetic variant and the risk of prostate cancer. Journal of Cellular Biochemistry. pp. 14822-14830. ISSN 0730-2312

(2019) The influence of a genetic variant in the KCNQ1 gene on type 2 diabetes mellitus development. Gene Reports. p. 4.

(UNSPECIFIED) A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients. Journal of Diabetes and Metabolic Disorders. p. 7.

(UNSPECIFIED) The role of the PPARG (Pro12Ala) common genetic variant on type 2 diabetes mellitus risk. Journal of Diabetes and Metabolic Disorders. p. 6.